329 related articles for article (PubMed ID: 18801898)
1. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle.
Amirouche A; Durieux AC; Banzet S; Koulmann N; Bonnefoy R; Mouret C; Bigard X; Peinnequin A; Freyssenet D
Endocrinology; 2009 Jan; 150(1):286-94. PubMed ID: 18801898
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
3. Rheb, an activator of target of rapamycin, in the blackback land crab, Gecarcinus lateralis: cloning and effects of molting and unweighting on expression in skeletal muscle.
MacLea KS; Abuhagr AM; Pitts NL; Covi JA; Bader BD; Chang ES; Mykles DL
J Exp Biol; 2012 Feb; 215(Pt 4):590-604. PubMed ID: 22279066
[TBL] [Abstract][Full Text] [Related]
4. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
5. Myostatin signaling regulates Akt activity via the regulation of miR-486 expression.
Hitachi K; Nakatani M; Tsuchida K
Int J Biochem Cell Biol; 2014 Feb; 47():93-103. PubMed ID: 24342526
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
Lang CH; Frost RA
J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
[TBL] [Abstract][Full Text] [Related]
7. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
[TBL] [Abstract][Full Text] [Related]
8. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
Hulmi JJ; Silvennoinen M; Lehti M; Kivelä R; Kainulainen H
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E307-15. PubMed ID: 22068602
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen improves protein translational signaling in aged skeletal muscle.
Wu M; Liu H; Fannin J; Katta A; Wang Y; Arvapalli RK; Paturi S; Karkala SK; Rice KM; Blough ER
Rejuvenation Res; 2010 Oct; 13(5):571-9. PubMed ID: 20818934
[TBL] [Abstract][Full Text] [Related]
11. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression.
Durieux AC; Amirouche A; Banzet S; Koulmann N; Bonnefoy R; Pasdeloup M; Mouret C; Bigard X; Peinnequin A; Freyssenet D
Endocrinology; 2007 Jul; 148(7):3140-7. PubMed ID: 17395701
[TBL] [Abstract][Full Text] [Related]
13. Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men.
Hulmi JJ; Tannerstedt J; Selänne H; Kainulainen H; Kovanen V; Mero AA
J Appl Physiol (1985); 2009 May; 106(5):1720-9. PubMed ID: 19299575
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor.
Gopinath SD
Skelet Muscle; 2017 Jan; 7(1):2. PubMed ID: 28122601
[TBL] [Abstract][Full Text] [Related]
15. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
[TBL] [Abstract][Full Text] [Related]
16. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways weigh in on decisions to make or break skeletal muscle.
Guttridge DC
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):443-50. PubMed ID: 15192448
[TBL] [Abstract][Full Text] [Related]
18. Calpastatin overexpression in the skeletal muscle of mice prevents clenbuterol-induced muscle hypertrophy and phenotypic shift.
Douillard A; Galbes O; Begue G; Rossano B; Levin J; Vernus B; Bonnieu A; Candau R; Py G
Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):364-72. PubMed ID: 22300302
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
20. Intermittent reloading attenuates muscle atrophy through modulating Akt/mTOR pathway.
Miyazaki M; Noguchi M; Takemasa T
Med Sci Sports Exerc; 2008 May; 40(5):848-55. PubMed ID: 18408614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]